New data on early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K.

This call for evidence is seeking the views of the public, as well as health and social care professionals, academics, employers and stakeholder organisations to inform a Men’s Health Strategy for Eng...

A community to discuss epinowcast and real-time infectious disease analysis more generally

55% of these companies regret making redundancies

The molecule targets bacteria in a way that other drugs don’t.

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine evaluation. A 2023–24 vaccine effectiveness analysis of immunocompetent adults age...